HRTX is currently developing the following drugs: Ibuprofen, Acetaminophen, Htx-011, Bupivacaine Hydrochloride, Luer Lock Applicator, Ibuprofen, Acetaminophen, Htx-011, Bupivacaine Hydrochloride, Luer Lock Applicator, Ibuprofen, Acetaminophen, Htx-011, Bupivacaine Hydrochloride, Luer Lock Applicator. These drug candidates are in various stages of clinical development as the company works toward FDA approval.